Skip to main content
Erschienen in: Cardiovascular Intervention and Therapeutics 1/2010

01.01.2010 | Original Article

Impact of catheter down-sizing and power injector use on the amount of contrast medium delivered

verfasst von: Tsuyoshi Nozue, Ichiro Michishita, Ichiro Mizuguchi

Erschienen in: Cardiovascular Intervention and Therapeutics | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study is to evaluate the effect of catheter down-sizing and power injector use on the amount of contrast medium delivered during diagnostic coronary angiography (CAG). We retrospectively studied 735 patients undergoing diagnostic CAG. Patients were divided into four groups according to catheter size [4 French (Fr) or 5 Fr] and the method of contrast injection (manual or power injection). Total contrast volume, procedure time, number of catheters used and angiogram quality were analyzed. Down-sizing catheters from 5 Fr to 4 Fr reduced the amount of contrast medium in both manual injection (from 153 ± 22 to 137 ± 17 ml, −10%, p < 0.0001) and power injection (from 135 ± 12 to 125 ± 16 ml, −7%, p < 0.0001). Introduction of power injection reduced the amount of contrast medium in both 4-Fr catheters (from 137 ± 17 to 125 ± 16 ml, −9%, p < 0.0001) and 5-Fr catheters (from 153 ± 22 to 135 ± 12 ml, −12%, p < 0.0001). A 28-ml (18%) reduction in contrast medium volume occurred when catheter down-sizing was combined with power injector use. Angiogram quality was not different among the four groups. Down-sizing the catheters from 5 Fr to 4 Fr and the use of a power injector reduced the amount of contrast medium delivered in CAG without reducing angiographic image quality.
Literatur
1.
Zurück zum Zitat Sones FM Jr, Shirey EK. Cine coronary arteriography. Mod Concepts Cardiovasc Dis. 1962;31:735–8.PubMed Sones FM Jr, Shirey EK. Cine coronary arteriography. Mod Concepts Cardiovasc Dis. 1962;31:735–8.PubMed
2.
Zurück zum Zitat Davis K, Kennedy JW, Kemp HG Jr, Judkins MP, Gosselin AJ, Killip T. Complications of coronary arteriography from the Collaborative Study of Coronary Artery Surgery (CASS). Circulation. 1979;59:1105–12.PubMed Davis K, Kennedy JW, Kemp HG Jr, Judkins MP, Gosselin AJ, Killip T. Complications of coronary arteriography from the Collaborative Study of Coronary Artery Surgery (CASS). Circulation. 1979;59:1105–12.PubMed
3.
Zurück zum Zitat Johnson LW, Lozner EC, Johnson S, Krone R, Pichard AD, Vetrovec GW, et al. Coronary arteriography 1984–1987: a report of the registry of the society for cardiac angiography and interventions. I. Results and complications. Cathet Cardiovasc Diagn. 1989;17:5–10.CrossRefPubMed Johnson LW, Lozner EC, Johnson S, Krone R, Pichard AD, Vetrovec GW, et al. Coronary arteriography 1984–1987: a report of the registry of the society for cardiac angiography and interventions. I. Results and complications. Cathet Cardiovasc Diagn. 1989;17:5–10.CrossRefPubMed
4.
Zurück zum Zitat Lefevre T, Morice MC, Bonan R, Dumas P, Louvard Y, Karrillon G, et al. Coronary angiography using 4 or 6 French diagnostic catheters: a prospective, randomized study. J Invasive Cardiol. 2001;13:674–7.PubMed Lefevre T, Morice MC, Bonan R, Dumas P, Louvard Y, Karrillon G, et al. Coronary angiography using 4 or 6 French diagnostic catheters: a prospective, randomized study. J Invasive Cardiol. 2001;13:674–7.PubMed
5.
Zurück zum Zitat Brown RI, MacDonald AC. Use of 5 French catheters for cardiac catheterization and coronary angiography: a critical review. Cathet Cardiovasc Diagn. 1987;13:214–7.CrossRefPubMed Brown RI, MacDonald AC. Use of 5 French catheters for cardiac catheterization and coronary angiography: a critical review. Cathet Cardiovasc Diagn. 1987;13:214–7.CrossRefPubMed
6.
Zurück zum Zitat Metz D, Chapoutot L, Brassellet C, Jolly D. Randomized evaluation of four versus five French catheters for transfemoral coronary angiography. Clin Cardiol. 1999;22:29–32.CrossRefPubMed Metz D, Chapoutot L, Brassellet C, Jolly D. Randomized evaluation of four versus five French catheters for transfemoral coronary angiography. Clin Cardiol. 1999;22:29–32.CrossRefPubMed
7.
Zurück zum Zitat Khoukaz S, Kern MJ, Bitar SR, Azrak E, Eisenhauer M, Wolford T, et al. Coronary angiography using 4 Fr catheters with acisted power injection: a randomized comparison to 6 Fr manual technique and early ambulation. Catheter Cardiovasc Interv. 2001;52:393–8.CrossRefPubMed Khoukaz S, Kern MJ, Bitar SR, Azrak E, Eisenhauer M, Wolford T, et al. Coronary angiography using 4 Fr catheters with acisted power injection: a randomized comparison to 6 Fr manual technique and early ambulation. Catheter Cardiovasc Interv. 2001;52:393–8.CrossRefPubMed
8.
Zurück zum Zitat Weinrauch LA, Healy RW, Leland OS Jr, Goldstein HH, Kassissieh SD, Libertino JA, et al. Coronary angiography and acute renal failure in diabetic azotemic nephropathy. Ann Int Med. 1977;86:56–9.PubMed Weinrauch LA, Healy RW, Leland OS Jr, Goldstein HH, Kassissieh SD, Libertino JA, et al. Coronary angiography and acute renal failure in diabetic azotemic nephropathy. Ann Int Med. 1977;86:56–9.PubMed
9.
Zurück zum Zitat Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: a prospective controlled study. N Engl J Med. 1989;320:143–9.PubMedCrossRef Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: a prospective controlled study. N Engl J Med. 1989;320:143–9.PubMedCrossRef
10.
Zurück zum Zitat Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous interventions. J Am Coll Cardiol. 2002;39:1113–9.CrossRefPubMed Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous interventions. J Am Coll Cardiol. 2002;39:1113–9.CrossRefPubMed
11.
Zurück zum Zitat McCullough PA, Wolyn R, Rocher LL, Levin RN, O’Neill WW. Acute renal failure after coronary intervention: incidence, risk factors and relationship to mortality. Am J Med. 1997;103:368–75.CrossRefPubMed McCullough PA, Wolyn R, Rocher LL, Levin RN, O’Neill WW. Acute renal failure after coronary intervention: incidence, risk factors and relationship to mortality. Am J Med. 1997;103:368–75.CrossRefPubMed
12.
Zurück zum Zitat Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259–64.CrossRefPubMed Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259–64.CrossRefPubMed
13.
Zurück zum Zitat Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000;36:1542–8.CrossRefPubMed Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000;36:1542–8.CrossRefPubMed
14.
Zurück zum Zitat Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. Ann Int Med. 1998;128:194–203.PubMed Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. Ann Int Med. 1998;128:194–203.PubMed
15.
Zurück zum Zitat Gruberg L, Mehran R, Dangas G, Mintz GS, Waksman R, Kent KM, et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv. 2001;52:409–16.CrossRefPubMed Gruberg L, Mehran R, Dangas G, Mintz GS, Waksman R, Kent KM, et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv. 2001;52:409–16.CrossRefPubMed
16.
Zurück zum Zitat Gruberg L, Dangas G, Mehran R, Mintz GS, Kent KM, Pichard AD, et al. Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter Cardiovasc Interv. 2002;55:66–72.CrossRefPubMed Gruberg L, Dangas G, Mehran R, Mintz GS, Kent KM, Pichard AD, et al. Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter Cardiovasc Interv. 2002;55:66–72.CrossRefPubMed
17.
Zurück zum Zitat Iakovou I, Dangas G, Mehran R, Lansky AJ, Ashby DT, Fahy M, et al. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol. 2003;15:18–22.PubMed Iakovou I, Dangas G, Mehran R, Lansky AJ, Ashby DT, Fahy M, et al. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol. 2003;15:18–22.PubMed
18.
Zurück zum Zitat Freeman RV, O’Donnell M, Share D, Meengs WL, Kline-Rogers E, Clark VL, et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol. 2002;90:1068–73.CrossRefPubMed Freeman RV, O’Donnell M, Share D, Meengs WL, Kline-Rogers E, Clark VL, et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol. 2002;90:1068–73.CrossRefPubMed
19.
Zurück zum Zitat Goldstein JA, Kern M, Wilson R. A novel automated injection system for angiography. J Interv Cardiol. 2001;14:147–52.CrossRefPubMed Goldstein JA, Kern M, Wilson R. A novel automated injection system for angiography. J Interv Cardiol. 2001;14:147–52.CrossRefPubMed
20.
Zurück zum Zitat Todd DM, Hubner PJ, Hudson N, Sarma J, McCance AJ, Caplin J. Multicentre, prospective, randomized trial of 4 vs. 6 French catheters in 410 patients undergoing coronary angiography. Catheter Cardiovasc Interv. 2001;54:269–75.CrossRefPubMed Todd DM, Hubner PJ, Hudson N, Sarma J, McCance AJ, Caplin J. Multicentre, prospective, randomized trial of 4 vs. 6 French catheters in 410 patients undergoing coronary angiography. Catheter Cardiovasc Interv. 2001;54:269–75.CrossRefPubMed
21.
Zurück zum Zitat Chahoud G, Khoukaz S, El-Shafei A, Azrak E, Bitar S, Kern MJ. Randomized comparison of coronary angiography using 4F catheters: 4F manual versus “Acisted” power injection technique. Catheter Cardiovasc Interv. 2001;53:221–4.CrossRefPubMed Chahoud G, Khoukaz S, El-Shafei A, Azrak E, Bitar S, Kern MJ. Randomized comparison of coronary angiography using 4F catheters: 4F manual versus “Acisted” power injection technique. Catheter Cardiovasc Interv. 2001;53:221–4.CrossRefPubMed
22.
Zurück zum Zitat Cigarroa RG, Lange RA, Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med. 1989;86:649–52.CrossRefPubMed Cigarroa RG, Lange RA, Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med. 1989;86:649–52.CrossRefPubMed
Metadaten
Titel
Impact of catheter down-sizing and power injector use on the amount of contrast medium delivered
verfasst von
Tsuyoshi Nozue
Ichiro Michishita
Ichiro Mizuguchi
Publikationsdatum
01.01.2010
Verlag
Springer Japan
Erschienen in
Cardiovascular Intervention and Therapeutics / Ausgabe 1/2010
Print ISSN: 1868-4300
Elektronische ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-009-0003-6

Weitere Artikel der Ausgabe 1/2010

Cardiovascular Intervention and Therapeutics 1/2010 Zur Ausgabe

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

PET kann infarktgefährdete Koronararterien entdecken

04.06.2024 Koronare Herzerkrankung Nachrichten

Der Nachweis aktiver Plaques mittels 18F-Natriumfluorid-PET hilft nicht nur, infarktgefährdete Patienten, sondern auch infarktgefährdete Koronararterien zu erkennen. Von einer gezielten Behandlung vulnerabler Plaques ist man trotzdem weit entfernt.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.